Display options
Share it on

Epidemiol Psychiatr Sci. 2013 Mar;22(1):17-9. doi: 10.1017/S2045796012000613. Epub 2012 Oct 23.

Dichotomizing rating scale scores in psychiatry: a bad idea?.

Epidemiology and psychiatric sciences

M Purgato, C Barbui

Affiliations

  1. Section of Psychiatry, Department of Public Health and Community Medicine, University of Verona, Verona, Italy.

PMID: 23089232 PMCID: PMC6998334 DOI: 10.1017/S2045796012000613

Abstract

In psychiatry, the use of rating scales as measures of outcome in clinical trials allows us to generate continuous outcome data, where each individual's outcome is measured in numbers. Continuous outcomes can be divided into two categories, such as improved and not improved, or may be kept continuous. This article briefly presents the main advantages and disadvantages of these two approaches, which are commonly employed in the analyses of rating scale scores in clinical trials and systematic reviews.

References

  1. BMJ. 2006 May 6;332(7549):1080 - PubMed
  2. N Engl J Med. 2005 Sep 22;353(12):1209-23 - PubMed
  3. BMJ. 1998 Feb 28;316(7132):690-3 - PubMed
  4. BMJ. 2005 Jul 16;331(7509):155-7 - PubMed
  5. CMAJ. 2008 Jan 29;178(3):296-305 - PubMed
  6. Epidemiol Psichiatr Soc. 2007 Apr-Jun;16(2):124-5 - PubMed

MeSH terms

Publication Types